Form 8-K - Current report:
SEC Accession No. 0001144204-18-056154
Filing Date
2018-10-30
Accepted
2018-10-30 16:18:46
Documents
5
Period of Report
2018-10-30
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K tv505782_8k.htm 8-K 545441
2 GRAPHIC tv505782_img1.jpg GRAPHIC 51952
3 GRAPHIC tv505782_img2.jpg GRAPHIC 53882
4 GRAPHIC tv505782_img3.jpg GRAPHIC 152525
5 GRAPHIC tv505782_img4.jpg GRAPHIC 30470
  Complete submission text file 0001144204-18-056154.txt   945150
Mailing Address 5 WEST FORSYTH STREET SUITE 200 JACKSONVILLE FL 32202
Business Address 5 WEST FORSYTH STREET SUITE 200 JACKSONVILLE FL 32202 (904) 516-5436
Marker Therapeutics, Inc. (Filer) CIK: 0001094038 (see all company filings)

EIN.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37939 | Film No.: 181147166
SIC: 2834 Pharmaceutical Preparations